drugset / Trial / NCT01213849
Dose Proportionality Study: Blood Levels of Fluticasone Furoate (FF) and Vilanterol (VI) Following Different Doses of FF/VI Via an Inhaler
RandomizedCrossoverOpen-labelBasic science
Summary
The purpose of this study is to demonstrate dose proportionality of fluticasone furoate (FF) and equivalence of vilanterol (VI)following single dose administration of FF/VI via the novel dry powder inhaler in healthy subjects.
Timeline
- Start
- 2010-10-04
- Primary completion
- 2010-11-25
- Completion
- 2010-11-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone Furoate | Other / unclassified | 50 ug | Inhaled |
| Subject | Fluticasone Furoate | Other / unclassified | 100 ug | Inhaled |
| Subject | Fluticasone Furoate | Other / unclassified | 200 ug | Inhaled |
| Subject | Vilanterol | Other / unclassified | 25 ug | Inhaled |